|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | |
| A61K 38/16 | |||
| A61K 38/17 | |||
| A61K 38/48 | |||
| A61K 35/17 | |||
| A61K 35/28 | |||
| A61K 35/30 | |||
| A61K 35/545 | |||
| C12N 5/00 | |||
| C12N 9/64 |
| (11) | Number of the document | 3004329 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14807405.7 |
| Date of filing the European patent application | 2014-06-04 | |
| (97) | Date of publication of the European application | 2016-04-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/040964 |
| Date | 2014-06-04 |
| (87) | Number | WO 2014/197638 |
| Date | 2014-12-11 |
| (30) | Number | Date | Country code |
| 201361831428 P | 2013-06-05 | US | |
| 201461949847 P | 2014-03-07 | US |
| (72) |
SLAWIN, Kevin, US
SPENCER, David, US
FOSTER, Aaron, Edward, US
|
| (73) |
Bellicum Pharmaceuticals, Inc.,
2130 West Holcombe Boulevard Ste. 850, Houston, TX 77030,
US
|
| (54) | METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES |
| METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES |